Contrast-enhanced US of Malignant Liver Tumors

Abstract Archives of the RSNA, 2009

VG21-10

Contrast-enhanced US of Malignant Liver Tumors

Multisession Courses

Presented on November 30, 2009
Presented as part of VG21: Ultrasound/Gastrointestinal Series: Contrast Agents in US

Participants

Hyun-Jung Jang MD, Presenter: Advisory Board, Lantheus Medical Imaging, Inc

LEARNING OBJECTIVES

1) To describe typical findings of common malignant liver tumors on contrast-enhanced ultrasound. 2) To understand the contribution of contrast-enhanced ultrasound in the characterization of nodules in cirrhotic patients. 3) To explain the advantages and limitations of contrast-enhanced ultrasound in the detection and characterization of malignant liver tumors, compared to CT or MRI.

ABSTRACT

Cite This Abstract

Jang, H, Contrast-enhanced US of Malignant Liver Tumors. Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8000445.html